Background: In radioembolization therapy for hepatic malignancies, the accurate estimation of lung shunt fraction (LSF) is crucial to minimize the risk of radiation-induced pneumonitis and fibrosis due to hepatopulmonary shunting of yttrium-90 (90Y)-microspheres. This study aimed to compare the accuracy and precision of LSF estimation using technetium-99m macroaggregated albumin single photon emission computed tomography ([99mTc]Tc-MAA SPECT) LSF, [99mTc]Tc-MAA planar LSF, and 90Y PET LSF in patients undergoing 90Y-radioembolization.
Material And Methods: A retrospective study was conducted involving 15 patients diagnosed with hepatocellular carcinoma (HCC) or liver metastases and planned to undergo transarterial radioembolization with 90Y SirSpheres after multidisplinary team discussion. LSF values were calculated using [99mTc]Tc-MAA SPECT LSF, [99mTc]Tc-MAA planar LSF, and 90Y PET LSF. The accuracy of these methods was assessed through paired t-tests and correlation analysis.
Results: The paired t-test revealed a statistically significant difference between SPECT LSF and planar LSF (t-statistic = -4.81, p-value = 0.0003), indicating that planar imaging tends to overestimate LSF values. However, no significant difference was observed between [99mTc]Tc-MAA SPECT LSF and 90Y PET LSF (t-statistic = -0.98, p-value = 0.343), suggesting a high degree of agreement between these two methods. Correlation analysis showed a very strong positive correlation between [99mTc]Tc-MAA SPECT LSF and 90Y PET LSF (r = 0.999), while strong correlations were also found between SPECT LSF and planar LSF, and between planar LSF and 90Y PET LSF (r = 0.841).
Conclusions: The findings suggest that 90Y PET LSF aligns closely with [99mTc]Tc-MAA SPECT LSF, making them both reliable for LSF estimation in radioembolization therapy. In contrast, planar imaging tends to overestimate LSF, potentially leading to inaccurate dosimetric planning. Incorporating [99mTc]Tc-MAA SPECT/CT and 90Y PET/CT into routine clinical practice could enhance the accuracy of LSF estimation, thereby improving patient outcomes. Further research with larger cohorts is recommended to validate these findings.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.5603/nmr.102284 | DOI Listing |
Eur J Nucl Med Mol Imaging
December 2024
Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, Bern, 3010, Switzerland.
Purpose: Long axial field-of-view (LAFOV) positron emission tomography/computed tomography (PET/CT) scanners enable high sensitivity and wide anatomical coverage. Therefore, they seem ideal to perform post-selective internal radiation therapy (SIRT) Y scans, which are needed, to confirm that the dose is delivered to the tumors and that healthy organs are spared. However, it is unclear to what extent the use of LAFOV PET is feasible and which dosimetry approaches results in accurate measurements.
View Article and Find Full Text PDFNucl Med Rev Cent East Eur
December 2024
Department of Radiology & Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care, and Research Center, Muscat, Oman.
Background: In radioembolization therapy for hepatic malignancies, the accurate estimation of lung shunt fraction (LSF) is crucial to minimize the risk of radiation-induced pneumonitis and fibrosis due to hepatopulmonary shunting of yttrium-90 (90Y)-microspheres. This study aimed to compare the accuracy and precision of LSF estimation using technetium-99m macroaggregated albumin single photon emission computed tomography ([99mTc]Tc-MAA SPECT) LSF, [99mTc]Tc-MAA planar LSF, and 90Y PET LSF in patients undergoing 90Y-radioembolization.
Material And Methods: A retrospective study was conducted involving 15 patients diagnosed with hepatocellular carcinoma (HCC) or liver metastases and planned to undergo transarterial radioembolization with 90Y SirSpheres after multidisplinary team discussion.
EJNMMI Phys
December 2024
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, 63130, USA.
Background: Prior studies have established that macroaggregated albumin (MAA)-SPECT/CT offers more robust lung shunt fraction (LSF) and lung mean absorbed dose (LMD) estimates in Y radioembolization in comparison to planar imaging. However, incomplete SPECT/CT coverage of the lungs is common due to clinical workflows, complicating its potential use for LSF and LMD calculations. In this work, lung truncation in MAA-SPECT/CT was addressed via correction strategies to improve Y treatment planning.
View Article and Find Full Text PDFCardiovasc Intervent Radiol
September 2024
Division of Vascular and Interventional Radiology, Department of Radiology, University of California, 200 West Arbor Dr, San Diego, California, 92103, USA.
Purpose: Transarterial radioembolization (TARE) for hepatocellular carcinoma (HCC) is performed after a mapping angiogram involving infusion of radiolabeled macroaggregated albumin to assess for non-target embolization and pulmonary shunting. The purpose of this case series was to evaluate the safety and feasibility of single-session TARE without the initial procedure.
Materials And Methods: A single-institution case series of 16 consecutive procedures on 15 patients with 18 tumors who underwent an attempted single-session TARE procedures with glass microspheres are presented.
J Vis Exp
May 2024
Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University; Department of Gastroenterology, The Second Affiliated Hospital of Nanchang University;
This study showcases a comprehensive treatment protocol for high-risk hepatocellular carcinoma (HCC) patients, focusing on the combined use of Y-90 transarterial radioembolization (TARE) and Programmed Cell Death-1 (PD-1) inhibitors as neoadjuvant therapy. Highlighted through a case report, it offers a step-by-step reference for similar therapeutic interventions. A retrospective analysis was conducted on a patient who underwent hepatectomy following Y-90 TARE and PD-1 inhibitor treatment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!